Centre Hospitalier Universitaire de Bordeaux - Hopital Saint Andre

Bordeaux 33075

4 studies enrolling now · 9 studies all time

What they study most

Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer, Cardiovascular Risk, Chronic Kidney Disease, EPP, Erythropoietic Protoporphyria (EPP), Heart Failure, Metastatic Castration-resistant Prostate Cancer, Non-small Cell Lung Cancer, NonSegmental Vitiligo, X-Linked Porphyria (XLP), X-Linked Protoporphyria (XLP), XLP

Studies at this site

• A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer — Recruiting now
• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
• Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP) — Recruiting now
• Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) — Recruiting now
• INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP — Completed
• Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) — Running, not enrolling
• A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer — Running, not enrolling
• A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1) — Running, not enrolling
• Levels of Inflammation in People With Cardiovascular Disease (POSEIDON) — Completed